73 related articles for article (PubMed ID: 2718450)
21. [Impairment of ventilatory parameters and exercise capacity in patients with pulmonary hypertension and chronic heart insufficiency].
Krüger S; Hoffmann R; Skobel E; Breuer C; Janssens U; Hanrath P
Dtsch Med Wochenschr; 2002 Apr; 127(16):839-44. PubMed ID: 11961700
[TBL] [Abstract][Full Text] [Related]
22. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
Franz IW; Van Der Meyden J; Schaupp S; Tönnesmann U
Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
24. [Lung function in chronic persistent pulmonary embolism].
Fischer BM; Kreiselmeyer M; Schlegel J; Schadmand S; Iversen S; Rupprecht HJ; Lorenz J; Ferlinz R
Pneumologie; 1995 Apr; 49(4):273-6. PubMed ID: 7792286
[TBL] [Abstract][Full Text] [Related]
25. [Pulmonary vascular input impedance in patients with pulmonary hypertension (author's transl)].
Haneda T; Nakajima T; Shirato K; Koiwa Y; Arai T; Kanazawa M; Ishikawa K; Ohe M; Hashiguchi R; Kanda H; Mimata T; Takishima T
Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Jan; 20(1):20-8. PubMed ID: 7098161
[No Abstract] [Full Text] [Related]
26. [Acute pulmonary hypertension treated with ibuprofen].
Eliasen K; Jensen NH; Andersen JB; Hasselstrøm L; Godtfredsen J
Ugeskr Laeger; 1986 Sep; 148(40):2554-5. PubMed ID: 3775954
[No Abstract] [Full Text] [Related]
27. [Observations on the effect of theophylline-ethylenediamine on pulmonary arterial blood pressure in patients with chronic cor pulmonale].
Pantzer M
Arzneimittelforschung; 1974 Jun; 24(6):947-9. PubMed ID: 4408081
[No Abstract] [Full Text] [Related]
28. Vasodilatory treatment of pulmonary hypertension.
Widimský J
Eur J Respir Dis; 1986 Mar; 68(3):161-6. PubMed ID: 2870937
[TBL] [Abstract][Full Text] [Related]
29. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
[TBL] [Abstract][Full Text] [Related]
30. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
[TBL] [Abstract][Full Text] [Related]
31. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure.
Reiter G; Reiter U; Kovacs G; Kainz B; Schmidt K; Maier R; Olschewski H; Rienmueller R
Circ Cardiovasc Imaging; 2008 Jul; 1(1):23-30. PubMed ID: 19808511
[TBL] [Abstract][Full Text] [Related]
33. [Changes induced by a new ergoline-like vasoactive substance on various parameters of the systemic and pulmonary circulation and on pneumoscintigraphic recording].
Cardaci G; Vittore F; Pigorini F
Clin Ter; 1972 Oct; 63(2):131-51. PubMed ID: 4644527
[No Abstract] [Full Text] [Related]
34. Inhalative iloprost - pharmacology and clinical application.
Ewert R; Schäper C; Halank M; Gläser S; Opitz CF
Expert Opin Pharmacother; 2009 Sep; 10(13):2195-207. PubMed ID: 19663611
[TBL] [Abstract][Full Text] [Related]
35. Reduction of acute pulmonary hypertension by prostacyclin.
Borchert J; Franke J; Lichey J
Cor Vasa; 1980; 22(4):281-7. PubMed ID: 7004773
[TBL] [Abstract][Full Text] [Related]
36. [Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema].
Yamazaki Y; Matsumoto H; Takeda A; Takahashi T; Sasaki N; Takahashi M; Tsuji T; Fujikane T; Shimizu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Aug; 35(8):847-53. PubMed ID: 9366158
[TBL] [Abstract][Full Text] [Related]
37. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
39. [Pulmonary flow velocity patterns in patients with pulmonary hypertension: a study using pulsed Doppler echocardiography combined with two-dimensional echocardiography (author's transl)].
Matsuda M; Sugishita Y; Yamaguchi T; Tamura T; Ito I
J Cardiogr; 1981 Jun; 11(2):603-14. PubMed ID: 7320540
[No Abstract] [Full Text] [Related]
40. Lowering pulmonary artery pressure in a patient with severe acute respiratory failure.
Hasselstrøm LJ; Eliasen K; Mogensen T; Andersen JB
Intensive Care Med; 1985; 11(1):48-50. PubMed ID: 3968302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
